StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) stock

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$433.93−12.35 (-2.77%)

Close on Nov 17, 2026Market cap $93.75BP/E 18.5Yield –

Elevance Health total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Elevance Health's total debt was $30.76B at Sep 30, 2026. For fiscal 2025 it was $32.05B, up 2.6% from the year before. Over ten years it grew 7.3% a year on average. The highest annual figure on record is $32.05B in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$32.05B+2.6%
FY2024Dec 31, 2024$31.23B+24.3%
FY2023Dec 31, 2023$25.12B+4.2%
FY2022Dec 31, 2022$24.11B+4.7%
FY2021Dec 31, 2021$23.03B+15.0%
FY2020Dec 31, 2020$20.04B-0.2%
FY2019Dec 31, 2019$20.09B+4.5%
FY2018Dec 31, 2018$19.21B-3.6%
FY2017Dec 31, 2017$19.93B+26.7%
FY2016Dec 31, 2016$15.73B-0.9%
FY2015Dec 31, 2015$15.86B+5.5%
FY2014Dec 31, 2014$15.04B+3.8%
FY2013Dec 31, 2013$14.49B-3.2%
FY2012Dec 31, 2012$14.98B+52.2%
FY2011Dec 31, 2011$9.84B+9.9%
FY2010Dec 31, 2010$8.95B+6.6%
FY2009Dec 31, 2009$8.40B-5.0%
FY2008Dec 31, 2008$8.84B–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$30.76B-4.2%
Q2 FY2026Jun 30, 2026$31.04B+2.8%
Q1 FY2026Mar 31, 2026$31.84B+6.1%
Q4 FY2025Dec 31, 2025$32.05B+2.6%
Q3 FY2025Sep 30, 2025$32.10B+18.2%
Q2 FY2025Jun 30, 2025$30.19B+9.0%
Q1 FY2025Mar 31, 2025$30.00B+13.4%
Q4 FY2024Dec 31, 2024$31.23B+24.3%
Q3 FY2024Sep 30, 2024$27.15B+9.3%
Q2 FY2024Jun 30, 2024$27.69B+10.2%
Q1 FY2024Mar 31, 2024$26.45B+3.9%
Q4 FY2023Dec 31, 2023$25.12B+4.2%
Q3 FY2023Sep 30, 2023$24.84B+4.5%
Q2 FY2023Jun 30, 2023$25.12B+6.5%
Q1 FY2023Mar 31, 2023$25.47B+9.5%
Q4 FY2022Dec 31, 2022$24.11B+4.7%
Q3 FY2022Sep 30, 2022$23.77B+4.3%
Q2 FY2022Jun 30, 2022$23.59B+1.5%
Q1 FY2022Mar 31, 2022$23.26B+0.1%
Q4 FY2021Dec 31, 2021$23.03B+15.0%
Q3 FY2021Sep 30, 2021$22.79B+9.3%
Q2 FY2021Jun 30, 2021$23.24B+8.2%
Q1 FY2021Mar 31, 2021$23.23B+7.2%
Q4 FY2020Dec 31, 2020$20.04B-0.2%
Q3 FY2020Sep 30, 2020$20.84B+3.0%
Q2 FY2020Jun 30, 2020$21.48B+11.3%
Q1 FY2020Mar 31, 2020$21.68B+12.1%
Q4 FY2019Dec 31, 2019$20.09B+4.5%
Q3 FY2019Sep 30, 2019$20.23B+4.2%
Q2 FY2019Jun 30, 2019$19.30B+0.1%
Q1 FY2019Mar 31, 2019$19.34B-2.7%
Q4 FY2018Dec 31, 2018$19.21B-3.6%
Q3 FY2018Sep 30, 2018$19.42B+19.6%
Q2 FY2018Jun 30, 2018$19.29B+18.4%
Q1 FY2018Mar 31, 2018$19.89B+16.0%
Q4 FY2017Dec 31, 2017$19.93B+26.7%
Q3 FY2017Sep 30, 2017$16.23B–
Q2 FY2017Jun 30, 2017$16.29B–
Q1 FY2017Mar 31, 2017$17.14B–
Q4 FY2016Dec 31, 2016$15.73B–

More Elevance Health figures

See a number that looks wrong?